July 17, 2026

Talking Medicines highlights the data opportunity emerging around GLP-1 care

Talking Medicines examines how the expanding GLP-1 market is increasing the importance of clear distinctions between approved therapies, compounded medicines and nutritional support...

SIRT6 positions Genflow Biosciences in a high-value area of longevity research

Genflow Biosciences is targeting SIRT6 as a potential route to improve DNA repair, metabolic control and healthier ageing...

Biotech Growth Trust portfolio company AtaiBeckley to be acquired by Eli Lilly

Eli Lilly’s proposed acquisition of AtaiBeckley values the biotechnology company at up to $3.8 billion, including contingent milestone payments. The transaction is the latest in a series of portfolio acquisitions..

Bridgepoint reports record first-half results as EBITDA rises 78%

Bridgepoint reported higher first-half earnings, record capital returns to fund investors and continued fundraising progress towards its updated target...

Burberry Group reports first-quarter growth across all major product categories

Burberry Group Plc said first-quarter FY2027 comparable retail sales rose 5%, driven by strong performance in the Americas and Greater China and growth across women’s, men’s, accessories and children’s divisions...

RM Plc Assessment Pipeline Doubles as RM Ava Opens New Growth Markets (video)

RM Plc CFO Simon Goodwin explains why the Assessment pipeline has doubled, how RM Ava could unlock new professional and government-regulated testing markets, and where further efficiencies will come from..

Total Graphite advances Madagascar optimisation and Mozambique development

Total Graphite is prioritising optimisation work at Vatomina and the updated Montepuez feasibility study as part of its wider portfolio review. The company reported US$1.5 million in unrestricted cash and..

Ibstock announces planned departure of independent non-executive director

Ibstock says Adepeju Adebajo will step down from the board on 23 September 2026 and a successor search will begin shortly...
Search

Funds

July 17, 2026

Talking Medicines highlights the data opportunity emerging around GLP-1 care

Talking Medicines examines how the expanding GLP-1 market is increasing the importance of clear distinctions between approved therapies, compounded medicines and nutritional support...

SIRT6 positions Genflow Biosciences in a high-value area of longevity research

Genflow Biosciences is targeting SIRT6 as a potential route to improve DNA repair, metabolic control and healthier ageing...

Biotech Growth Trust portfolio company AtaiBeckley to be acquired by Eli Lilly

Eli Lilly’s proposed acquisition of AtaiBeckley values the biotechnology company at up to $3.8 billion, including contingent milestone payments. The transaction is the latest in a series of portfolio acquisitions contributing to BIOG’s performance...

Bridgepoint reports record first-half results as EBITDA rises 78%

Bridgepoint reported higher first-half earnings, record capital returns to fund investors and continued fundraising progress towards its updated target...

Burberry Group reports first-quarter growth across all major product categories

Burberry Group Plc said first-quarter FY2027 comparable retail sales rose 5%, driven by strong performance in the Americas and Greater China and growth across women’s, men’s, accessories and children’s divisions. The luxury brand highlighted momentum in outerwear, scarves and e-commerce, along with rising new customer acquisition and improved wholesale guidance for the first half...

RM Plc Assessment Pipeline Doubles as RM Ava Opens New Growth Markets (video)

RM Plc CFO Simon Goodwin explains why the Assessment pipeline has doubled, how RM Ava could unlock new professional and government-regulated testing markets, and where further efficiencies will come from after £20 million of annualised savings...

Total Graphite advances Madagascar optimisation and Mozambique development

Total Graphite is prioritising optimisation work at Vatomina and the updated Montepuez feasibility study as part of its wider portfolio review. The company reported US$1.5 million in unrestricted cash and continues discussions with financial institutions and potential strategic partners...

Ibstock announces planned departure of independent non-executive director

Ibstock says Adepeju Adebajo will step down from the board on 23 September 2026 and a successor search will begin shortly...
Search

Funds

July 17, 2026

FTSE 100

Funds